These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19404737)

  • 1. Extracellular matrix fibrotic markers in heart failure.
    Zannad F; Rossignol P; Iraqi W
    Heart Fail Rev; 2010 Jul; 15(4):319-29. PubMed ID: 19404737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockers in older patients.
    Weber MA
    Am J Geriatr Cardiol; 2004; 13(4):197-205; quiz 206-7. PubMed ID: 15269566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
    Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of extracellular matrix turnover.
    Zannad F; Pitt B
    Heart Fail Clin; 2009 Oct; 5(4):589-99. PubMed ID: 19631182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular remodeling and angiotensin-converting enzyme inhibitors.
    Goldstein S; Sabbah H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S27-31. PubMed ID: 7700061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qishenyiqi Dropping Pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation.
    Wang J; Lu L; Wang Y; Wu Y; Han J; Wang W; Li C; Tu P
    J Ethnopharmacol; 2015 Dec; 176():375-84. PubMed ID: 26590099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular remodelling: consequences and therapy.
    Sabbah HN; Goldstein S
    Eur Heart J; 1993 Jul; 14 Suppl C():24-9. PubMed ID: 8365425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial collagen matrix remodelling in arterial hypertension.
    Brilla CG; Maisch B; Weber KT
    Eur Heart J; 1992 Sep; 13 Suppl D():24-32. PubMed ID: 1396856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study.
    Barasch E; Gottdiener JS; Aurigemma G; Kitzman DW; Han J; Kop WJ; Tracy RP
    Circ Heart Fail; 2009 Jul; 2(4):303-10. PubMed ID: 19808353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
    Jessup JA; Westwood BM; Chappell MC; Groban L
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):245-57. PubMed ID: 19531557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril on interstitial collagen in the myocardium after infarction in rats.
    Milanez MC; Gomes MG; Vassallo DV; Mill JG
    J Card Fail; 1997 Sep; 3(3):189-97. PubMed ID: 9330127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats.
    Varo N; Iraburu MJ; Varela M; López B; Etayo JC; Díez J
    Hypertension; 2000 Jun; 35(6):1197-202. PubMed ID: 10856263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of the extracellular matrix and of collagen fragments.
    Chalikias GK; Tziakas DN
    Clin Chim Acta; 2015 Mar; 443():39-47. PubMed ID: 25007952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
    Ciulla MM; Paliotti R; Esposito A; Cuspidi C; Muiesan ML; Rosei EA; Magrini F; Zanchetti A
    J Hypertens; 2009 Mar; 27(3):626-32. PubMed ID: 19262230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
    Yamamoto K; Mano T; Yoshida J; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
    J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.